Posted by AGORACOM-JC
at 7:55 AM on Thursday, January 7th, 2021
When a small cap company enters into a developer and supply agreement with a technology leader in its space AND can’t name the company, that is typically a very good thing.
Understanding the world of Photonics isn’t the easiest thing small cap investors have had to understand. In fact, it may be the very hardest thing they’ve ever had to understand. However, given the fact we are the very reason current photonics devices aren’t living up to snuff trying to keep up with our surfing, streaming, binging and zooming – you start to see why understanding photonics and POET Technologies could open up investors to a whole new world.
Before watching this video, here is some important background information.
Photonic devices create, detect and manipulate light. Laser generated light is fundamental to sensing, computing, data and telecommunications, which require the fastest transfer of data possible.
This is where POET comes in.
Why? All the surfing, streaming, binging and zooming we do requires 2 things to happen:
1. Massive data centres filled with tens of thousands of servers.
2. Speed … and we mean lighting speed that requires lasers to transfer all that data fast enough for you not to complain about 2 second latency when searching for weight-loss programs for your New Year’s resolution (We see you).
Examples of the the biggest trends sucking up all that power and speed in computing today:
Cloud Computing
Artificial Intelligence
5G and Edge
HERE IS THE PROBLEM
Making photonics devices that are reliable is expensive in terms of both capital and labor. Unlike almost every electronic device or component on this planet that has seen their costs drop dramatically over time, photonics cost declines have not kept up with Moore’s Law, with most photonics devices built one at a time. (NOT A TYPO).
The Result? Integration of components at wafer-scale has not been fully implemented even by the largest companies working for the past 20 years ….. UNTIL NOW
POET has developed a unique, disruptive and differentiating new entry into photonics markets – The POET Optical Interposer™ Platform. Don’t worry if that sounds like a mouthful. All you have to know is that it
Enables lower cost
Delivers higher performance
Across a wide range of applications like those mentioned above
Today’s press release announcing its entry into the “Artificial Intelligence Market with Technology Leader in Photonic Computing” serves as great 3rd party validation that POET Technologies can open up the AI market for its Optical Interposer Platform.
Watch this great interview with:
Suresh Venkatesan, Chairman and CEO
Vivek Rajgarhia, President & General Manager
Thomas Mika, Executive Vice President and Chief Financial Officer
Posted by AGORACOM-JC
at 9:33 AM on Wednesday, January 6th, 2021
Announced the awarding of a new patent for a vertical take-off and landing (VTOL) cargo delivery drone with variable center of gravity.
The design is ideal for Beyond Visual Line of Sight (BVLOS) and for transporting goods in hard to reach areas or flight over people at night.
Los Angeles, CA, Jan. 06, 2021 — Draganfly Inc. (OTCQB: DFLYF) (CSE: DFLY) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading manufacturer and systems developer, is pleased to announce the awarding of a new patent for a vertical take-off and landing (VTOL) cargo delivery drone with variable center of gravity.
The design is ideal for Beyond Visual Line of Sight (BVLOS) and for transporting goods in hard to reach areas or flight over people at night.
US Patent No. 10,807,707 is an unmanned aircraft system (UAS) configured for both vertical take-off and landing (VTOL) and fixed-wing flight operations includes forward, and aft wing assemblies mounted to the fuselage, each wing assembly including port and starboard nacelles terminating in motor-driven rotors powered by an onboard control system capable of adjusting rotor speeds.
Posted by AGORACOM-JC
at 8:19 AM on Wednesday, January 6th, 2021
Entered into development and supply agreements with a technology leader in photonic neural network systems for Artificial Intelligence (AI) applications.
Artificial Intelligence, at the cusp of its own revolutionary impact to humanity, is driving an unprecedented demand for computation at the same time that the physics of digital semiconductors, driven by Moore’s law, is reaching its end.
Chipset market for AI applications is projected to grow from approximately $18 billion in 2020 to over $65 billion by 2025.
TORONTO, Jan. 06, 2021 — POET Technologies Inc. (“ POET ” or the “ Company ”) (TSX Venture: PTK; OTCQX: POETF), the designer and developer of the POET Optical Interposer and Photonic Integrated Circuits (PICs) for the data center and tele-communication markets, today announced that it has entered into development and supply agreements with a technology leader in photonic neural network systems for Artificial Intelligence (AI) applications.
Artificial Intelligence, at the cusp of its own revolutionary impact to humanity, is driving an unprecedented demand for computation at the same time that the physics of digital semiconductors, driven by Moore’s law, is reaching its end. Transistor scaling is approaching its limits and AI accelerator companies are struggling to keep pace with demands, particularly in “edge” applications that require greater power and cost efficiency. Domain-specific architectures targeted to AI workloads can make up for some of the slowdown in transistor advances but that approach also has its limits.
Posted by AGORACOM-JC
at 11:11 AM on Tuesday, January 5th, 2021
Announced two investments, for a total of $530,000 in Electric Metals (USA) Ltd. a multi-commodity US-based resource company focused on their 100% owned Corcoran Canyon Silver Project in Nevada and Emily Manganese Project in Minnesota.
In the first private placement, The Company has acquired 1,000,000 shares (the “Shares”) at a price of $0.20 per Share in EML.
In the second private placement, The Company has acquired 1,000,000 Subscription Receipts at a price of $0.33 per Sub Receipts. Each Sub Receipts will entitle ThreeD to receive one (1) common share of EML (a “Common Share”) and one-half (1/2) of one Common Share purchase warrant (each whole warrant, a “Warrant”), with each whole warrant exercisable at $0.60 per Warrant.
The Warrants will expire two (2) years from the date of issuance.
Sheldon Inwentash has also agreed to come on as Chairman of the Board of Directors to NBS, which will take effect upon the closing of the proposed transaction with NBS.
TORONTO, Jan. 05, 2021 — ThreeD Capital Inc. (“ThreeD” or the “Company”) (CSE:IDK) (OTCQB:IDKFF) a Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors, is pleased to announce two investments, for a total of $530,000 in Electric Metals (USA) Ltd. (“EML ”), a multi-commodity US-based resource company focused on their 100% owned Corcoran Canyon Silver Project in Nevada and Emily Manganese Project in Minnesota.
In the first private placement, The Company has acquired 1,000,000 shares (the “Shares”) at a price of $0.20 per Share in EML.
In the second private placement, The Company has acquired 1,000,000 Subscription Receipts (the “Sub Receipts”) at a price of $0.33 per Sub Receipts. Each Sub Receipts will entitle ThreeD to receive one (1) common share of EML (a “Common Share”) and one-half (1/2) of one Common Share purchase warrant (each whole warrant, a “Warrant”), with each whole warrant exercisable at $0.60 per Warrant. The Warrants will expire two (2) years from the date of issuance.
EML signed a definitive scheme implementation agreement, effective 31st December 2020, with NBS Capital Inc. (“NBS”) (TSXV: NBS.P), as announced yesterday by NBS. Pursuant to this Agreement, NBS will acquire all of the shares of EML via share exchange for an equivalent number of NBS shares, which will result in EML becoming a wholly owned subsidiary of NBS. NBS will change its name change to Nevada Silver Corporation on closing of the proposed transaction, reflecting the focus of EML on its principal Nevada silver asset.
Sheldon Inwentash has also agreed to come on as Chairman of the Board of Directors to NBS, which will take effect upon the closing of the proposed transaction with NBS.
Sheldon Inwentash, Chairman and CEO of ThreeD Capital stated “ThreeD Capital prides itself on discovering great companies before they become known to the general investment community, and EML is no exception. With 100% ownership of a US-based primary silver-gold asset with existing resources and significant upside potential, I am confident EML will deliver exceptional value to IDK shareholders.”
Gary Lewis, Director and CEO of EML commented, “We are delighted to welcome ThreeD Capital onto the EML register and Mr. Sheldon Inwentash as our incoming Chairman at such a pivotal time in the company’s development. EML has built a strong asset base and technical capability which, when coupled with the reputation, rolodex and investment nous of Mr. Inwentash, will make for a very compelling combination.”
EML is an unlisted public company incorporated under the laws of New South Wales, Australia. It is a U.S.-based resource company, with its material asset being the 100-per-cent-owned Corcoran Canyon silver project in Nevada. EML also holds a high-grade manganese project in Minnesota, United States.
About ThreeD Capital Inc.
ThreeD is a publicly-traded Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors. ThreeD’s investment strategy is to invest in multiple private and public companies across a variety of sectors globally. ThreeD seeks to invest in early stage, promising companies where it may be the lead investor and can additionally provide investees with advisory services and access to the Company’s ecosystem.
For further information: Gerry Feldman, CPA, CA Chief Financial Officer and Corporate Secretary [email protected] Phone: 416-941-8900 ext 106
The Canadian Securities Exchange has neither approved nor disapproved the contents of this news release and accepts no responsibility for the adequacy or accuracy hereof.
Forward-Looking Statements
This news release contains certain forward-looking statements and forward-looking information (collectively referred to herein as “forward-looking statements”) within the meaning of Canadian securities laws including, without limitation, statements with respect to the future investments by the Company. All statements other than statements of historical fact are forward-looking statements. Undue reliance should not be placed on forward-looking statements, which are inherently uncertain, are based on estimates and assumptions, and are subject to known and unknown risks and uncertainties (both general and specific) that contribute to the possibility that the future events or circumstances contemplated by the forward-looking statements will not occur. Although the Company believes that the expectations reflected in the forward looking statements contained in this press release, and the assumptions on which such forward-looking statements are made, are reasonable, there can be no assurance that such expectations will prove to be correct. Readers are cautioned not to place undue reliance on forward-looking statements included in this document, as there can be no assurance that the plans, intentions or expectations upon which the forward-looking statements are based will occur. By their nature, forward-looking statements involve numerous assumptions, known and unknown risks and uncertainties that contribute to the possibility that the predictions, forecasts, projections and other forward-looking statements will not occur, which may cause the Company’s actual performance and results in future periods to differ materially from any estimates or projections of future performance or results expressed or implied by such forward-looking statements. The forward-looking statements contained in this news release are made as of the date hereof and the Company does not undertake any obligation to update publicly or to revise any of the included forward-looking statements, except as required by applicable law. The forward-looking statements contained herein are expressly qualified by this cautionary statement.
Posted by AGORACOM-JC
at 1:06 PM on Thursday, December 31st, 2020
Famed Canadian Investor Sheldon Inwentash Founder, Chairman and CEO ThreeD Capital praises Loop Insights. Inwentash is extremely impressed with the company’s technology and goes on to say that Loop Insights CEO Rob Anson is the hardest working small cap CEO he knows.
Posted by AGORACOM
at 10:30 AM on Wednesday, December 30th, 2020
ThreeD Capital Inc. (“ThreeD” or the “Company”) (CSE:IDK) (OTCQB:IDKFF), a Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors, is pleased to announce a US$450,000 investment in Wuhan General Group (China) Inc. (OTC PINK:WUHN) (“Wuhan”), a bioceutical company focused on alternative plant-based cannabinoids and psilocybin medical research.
The Company will acquire 1,500,000 units (the “Units”) at a price of US$0.30 per Unit. Each Unit will consist of one (1) common share of Wuhan (a “Common Share”) and one Common Share purchase warrant (a “Warrant”) exercisable at US$0.30 per Warrant. The Warrants will expire three (3) years from the date of issuance. The closing date for the private placement will be at the latest on January 31, 2021.
Sheldon Inwentash, Chairman and CEO of ThreeD Capital stated, “The investment thesis of ThreeD Capital is that psychedelics are going to experience a paradigm shifting and parabolic growth stage over this decade, leading to a critical role in the treatment of anxiety, depression, addiction and other mental health issues that traditional pharmaceuticals have not been able to adequately solve. Though we have made other smaller investments in the space, our investment in Wuhan General Group (China) represents our largest investment to date in a psychedelics company. We are investing in Wuhan General Group (China) because of the deep expertise and scientific knowledge this company has in psychedelics.”
Wuhan General Group (China) Inc., through its wholly-owned subsidiary MJ MedTech is a nutraceutical biotechnology company focused on alternative plant-based cannabinoids and psilocybin medical research that develops and commercializes a range of CBD and mushrooms-based products under Dr. AnnaRx™, Medspresso™ and Handcrafted Delights™ brands. In addition, our research and clinical trials with psilocybin are aimed at new therapies that will help patients who suffer from alcohol addiction, mental illness and cardiovascular diseases. Our mission is to advance botanical-based medicine to the forefront by deploying best-practice science and medicine, clinical research and emerging technologies. The Company is traded on the Over-the-Counter Bulletin Board of NASDAQ under the trading symbol “WUHN”.
About ThreeD Capital Inc.
ThreeD is a publicly-traded Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors. ThreeD’s investment strategy is to invest in multiple private and public companies across a variety of sectors globally. ThreeD seeks to invest in early stage, promising companies where it may be the lead investor and can additionally provide investees with advisory services and access to the Company’s ecosystem.
Posted by AGORACOM
at 8:32 AM on Tuesday, December 29th, 2020
Valeo Pharma Inc. (CSE: VPH) (OTCQB: VPHIF) (FSE: VP2) (“Valeo“), a Canadian pharmaceutical company, announced today that its common shares are now eligible for electronic clearing and settlement through the Depository Trust Company (“DTC”) in the United States.
“We are pleased to have secured DTC eligibility to facilitate the trading of our common shares for U.S investors and brokerage firms. This will allow for faster execution and improved liquidity which will help with broadening our investor base”, said Steve Saviuk, President and CEO.
DTC is a subsidiary of the Depository Trust & Clearing Corporation, a U.S. company that manages the electronic clearing and settlement of publicly traded companies. Securities that are eligible to be electronically cleared and settled through DTC are considered “DTC eligible”. This electronic method of clearing securities speeds up the receipt of stock and cash, and thus accelerates the settlement process for investors and brokers, enabling the stock to be traded over a much wider selection of brokerage firms.
Valeo has also engaged Native Ads Inc. (“Native Ads”), a full service advertising agency, to provide digital media services, vendor management, marketing and data analytics services to Valeo and has budgeted USD $250,000 for such services over an expected 12 month period. Neither Native Ads or any of its directors and officers own any securities in Valeo.
About Valeo Pharma
Valeo Pharma is a pharmaceutical company dedicated to the commercialization of innovative prescription products in Canada with a focus on Neurodegenerative Diseases, Oncology and Hospital Specialty Products. Headquartered in Kirkland, Quebec Valeo Pharma has the full capability and complete infrastructure to register and properly manage its growing product portfolio through all stages of commercialization. For more information, please visit www.valeopharma.comand follow us on LinkedIn and Twitter.
Posted by AGORACOM-JC
at 7:09 AM on Wednesday, December 23rd, 2020
Though the Company has executed contracts totaling approximately $775,000 in the calendar year, the value of these contracts will not be fully reflected in the fiscal year financials due to the fact some of the agreements were signed after August 31.
Moreover, given the SaaS business model of the Company, revenues are recognized pro-rata over the life of the term of each contract, which can range from 1 – 5 years.
Nonetheless, the approximate $775,000 record revenue from these contracts will be received and recognized by the Company.
VANCOUVER, BC , Dec. 23, 2020 – Imagine AR Inc. (CSE: IP) (OTCQB: IPNFF) (“ImagineAR” or “Company”) an Augmented Reality Company that enables businesses, sports teams and organizations to create instant AR campaigns without a technical background, is pleased to provide investors with a corporate update for calendar 2020, the Company’s best year. Specifically, the Company set records in two key performance indicators (KPI’s):
Total Executed AR Contracts
$775,000 *
Total Proceeds from Financing
$6,000,000 (approximate)
* Approximate Augmented Reality Enterprise, White Label, and SDK contracts
ImagineAR CEO, Alen Paul Silverrstieen said “By every KPI, ImagineAR turned in its best calendar year performance ever. Despite the early negative impact to our sales pipeline as a result of COVID-19 shutting down live events, the pendulum swung quickly as sports teams, corporations and entertainers turned to augmented reality to generate new revenue opportunities through our platform’s ability to create direct mobile engagement and activations. We are very proud of our performance from both a sales and technology development point of view.”
The Company is filing its audited 2020 financials and MD&A for the fiscal year ended August 31, 2020 on SEDAR by the end of this month. Though the Company has executed contracts totaling approximately $775,000 in the calendar year, the value of these contracts will not be fully reflected in the fiscal year financials due to the fact some of the agreements were signed after August 31.
Moreover, given the SaaS business model of the Company, revenues are recognized pro-rata over the life of the term of each contract, which can range from 1 – 5 years. Nonetheless, the approximate $775,000 record revenue from these contracts will be received and recognized by the Company.
Silverrstieen added “Looking forward into 2021, though COVID-19 was a significant short-term catalyst in 2020, our pipeline clearly indicates it also accelerated the inevitable adoption of AR by 2-3 years, leading to our confident expectation that 2021 will see even greater increases than 2020. We fully expect to deliver news related to new contract wins in early 2021.”
Major New Global Clients
The Company had its best year of augmented reality contracts around the world in 2020.
Five Year White Label Contract with SlapitOnAR, a company owned and operated by true legends in the world of sports in the United States . CEO Mike Vanderjagt , NFL All-Pro Placekicker is the founder and his partners include Johnny Damon (MLB), Mike Modano (NHL), Troy Aikman (NFL), Steve Smith (NBA), and Cobi Jones (MLS).
Five Year White Label Contract with WaV Sports & Entertainment starting with a launch of the NFL Alumni Academy Subscription Mobile App early 2021.
Two Year Partnership with Valencia CF of La Liga in Spain installing the ImagineAR SDK in December 2020 .
Two Year Partnership with Royal Sociedad of La Liga in Spain installing the ImagineAR SDK in February 2021 .
Shoppers Drug Mart White Label Contract for Company-wide Training in 2021.
Business Partnership with India Music Superstar Ananya Birla to Launch ImagineAR for Consumers and Business in India . Ananya music videos have over 350 million views across all social platforms.
North American AR Consumer Campaigns
The Company launched three major consumer AR campaigns in North America .
Jacob “Stitch” Duran Promotion for the Fury vs. Wilder 2 Heavyweight Championship.
In partnership with the Broward Education Foundation, Flo Rida AR Campaign was launched in June 2020 . This AR campaign was covered in the United States by NBC, CBS, NPR, NY Times, Forbes, and many other media publications.
Free Virtual Santa Claus ImagineAR campaign was launched in December 2020 and has been already featured in media including CBS, The Guardian, KTLA, Military Families, and others.
$6,000,000 From Financing & Warrant Redemptions
Confidence in the Company’s augmented reality abilities was also demonstrated by the capital markets with ImagineAR receiving record proceeds from financing in 2020 of approximately $6,000,000 , including approximately $4,500,000 from the exercise of warrants over this summer. As a result, the Company is well financed for growth through to the end of 2021.
HOLIDAY WISHES
The Company wishes its investors in North America and across the world safe and happy holidays.
Most of all, ImagineAR extends its thanks and appreciation to all shareholders for their support and looks forward to achieving even greater things together in 2021.
This News Release is available on the company’s CEO Verified Discusion Forum , a moderated social media platform that enables civilized discussion and Q&A between Management and Shareholders.
About ImagineAR
ImagineAR Inc. (CSE: IP) (OTC: IPNFF) is an augmented reality (AR) platform, ImagineAR.com, that enables businesses of any size to create and implement their own AR campaigns with no programming or technology experience. Every organization, from professional sports franchises to small retailers, can develop interactive AR campaigns that blend the real and digital worlds. Customers simply point their mobile device at logos, signs, buildings, products, landmarks and more to instantly engage videos, information, advertisements, coupons, 3D holograms and any interactive content all hosted in the cloud and managed using a menu-driven portal. Integrated real-time analytics means that all customer interaction is tracked and measured in real-time. The AR Enterprise platform supports both IOS and Android mobile devices and upcoming wearable technologies.
All trademarks of the property of respective owners.
We encourage you to do your own due diligence and ask your broker if ImagineAR Inc. (cse: IP) is suitable for your particular investment portfolio*.
The Canadian Securities Exchange has neither approved nor disapproved the contents of this press release. This press release may include ‘forward-looking information’ within the meaning of Canadian securities legislation, concerning the business of the Company. The forward-looking information is based on certain key expectations and assumptions made by Imagination Park’s management. Although ImagineAR believes that the expectations and assumptions on which such forward- looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because ImagineAR can give no assurance that it will prove to be correct. These forward-looking statements are made as of the date of this press release, and ImagineAR disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.
Posted by AGORACOM-JC
at 6:00 PM on Tuesday, December 22nd, 2020
Valeo Pharma is already a successful, revenue generating, small cap Canadian pharmaceutical company that acquires the Canadian rights to commercialized drugs in other parts of the world that don’t have Canada on their radar as a target market.
This “in-license” business model is ingenious because it means ZERO developmental or clinical risk, which is the downfall of most small cap pharma companies.
This model has resulted in the following success:
$5.3M in revenues in the first 9 months of 2020 (ending July 31, 2020)
9 products currently in the market with an annual estimated peak sales of $40M/year
7 products in the pipeline with an annual estimated peak sales of $45M/year
In fact, capital markets confidence is so high that Valeo secured $8.6M in financing in the last half of the year with:
$6.9M Bought Deal financing at $1.20/shares
A $1.7M Oversubscribed debenture (non-convertible)
If that was all Valeo had, most investors would be happy to sit back and watch the Company grow.
But then came Redesca. We are going to save you the science and tell you that Redesca belongs to a class of anticoagulant medications (blood thinners) called LMWH. The size of the Canadian LMWH market is over $200M per year and Valeo believes they can capture 15-30% of this market. If you’re doing back of napkin math, that equates to $30,000,000 – $60,000,000 per year in revenues.
But how does a new product capture that much market share? Glad you asked because we asked CEO Steve Saviuk the same question. Competition is tough in all markets and they don’t let someone take 15-30% market share without one hell of a fight. Saviuk agreed and gave the following 3 reasons:
1. Redesca has an 8-year international track record of safety and efficacy. It is already well known
2. Redesca is flat out cheaper, which is music to the ears of Provincial Health Ministries whose budgets have been stretched to the max this year no thanks to COVID-19.
Vaelo is so confident that it stated “This is great news for the Canadian healthcare system …. and is expected to help provide significant savings to provincial healthcare systems.”
Well there you have it. Valeo is a great story. Watch the video.
HOLD ON. THERE’S MORE … A LOT MORE
In addition to being used primarily for treating and preventing deep vein thrombosis and pulmonary embolism, LMWH are also now increasingly used as a first line of defense tool in the fight against Covid-19. The World Health Organization’s (“WHO”) issued guidance regarding the prophylaxis use of LMWH to help prevent complications in the clinical management of severe acute respiratory infections when COVID-19 infection is suspected.
The Canadian market for LMWH was already at a healthy $200M + per year when Valeo started down the Redesca path 4 years ago. Now it gets the added kicker of Redesca being a first line of defense to fight COVID-19.
Now you have it. That’s the Valeo story as it applies to Redesca. There is a whole lot more to the story given their pipeline of products but we couldn’t cover it all in this great interview with CEO Steve Saviuk.
If you love revenue generating, growing and blue sky potential small cap companies, then this Valeo interview is a must watch.
